3Coroneo MT, Di Gieolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Opthalmol, 1999, 10:282-288.
4Hill JC, Maske R. Pathogenesis of pterygium. Eye, 1989, 3:218-226.
5Tan DT, Chee SP, Dear KB, et al. Effect of pterygium morphology on ptrygium recurrence in a controlled trial comparing conjunctival autogfrafting with bare sclera excision. Arch Ophthahnol, 1997,115; 1235-1240.
6Di Girolamo N, Coroneo MT, Wakefield D. Aative matrilysin(MMP - 7) in human pterygia: otential role in angiogenesis. Invest Ophthal mol Vis Sci, 2001, 78:663-672.
7Kria L, Ohira A, Amemiya T. Immunohistochemical localization of basic fibrolast growth factor, platelet derived growth factor, transforming growth factor-beta and tumor necrosis factor-alpha in the pterygium. Acta Histochem, 1996, 98:195-201.
8Kria L, Ohira A, Amemiya T. Growth factors in cultured pterygium fibroblsts: immunohistochemical and ELISA analysis. Graefes Arch Clin Exp Ophthalmol, 1998, 236:702-708.
9Lee DH, Cho HJ, Kim JT, et al. Expression of VEGF and inducible nitric oxide synthase in pterygia. Cornea, 2001, 20:738-742.
10EO'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 1997, 88:277- 285.
